Healthcare provider profile · identity verified

Sefako Phala, MD

Family Practice · BAY CITY, MI · NPI 1659869139

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	339	45
Atorvastatin Calcium	Atorvastatin Calcium	232	71
Gabapentin	Gabapentin	193	34
Levothyroxine Sodium	Levothyroxine Sodium	173	41
Amlodipine Besylate	Amlodipine Besylate	165	47
Omeprazole	Omeprazole	136	47
Metformin Hcl	Metformin Hcl	131	38
Rosuvastatin Calcium	Rosuvastatin Calcium	124	41
Pantoprazole Sodium	Pantoprazole Sodium	120	29
Alprazolam	Alprazolam	114	21
Lisinopril	Lisinopril	114	35
Tramadol Hcl	Tramadol Hcl	106	26
Losartan Potassium	Losartan Potassium	100	27
Trazodone Hcl	Trazodone Hcl	91	21
Hydrochlorothiazide	Hydrochlorothiazide	86	26
Prednisone	Prednisone	75	43
Duloxetine Hcl	Duloxetine Hcl	74	14
Albuterol Sulfate Hfa	Albuterol Sulfate	71	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	66	22
Simvastatin	Simvastatin	63	21
Fluoxetine Hcl	Fluoxetine Hcl	62	13
Furosemide	Furosemide	56	18
Pregabalin	Pregabalin	55	12
Eliquis	Apixaban	51	13
Olmesartan Medoxomil	Olmesartan Medoxomil	50	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	19
Metoprolol Tartrate	Metoprolol Tartrate	49	17
Sertraline Hcl	Sertraline Hcl	49	18
Tamsulosin Hcl	Tamsulosin Hcl	48	17
Famotidine	Famotidine	47	18
Carvedilol	Carvedilol	45	12
Metoprolol Succinate	Metoprolol Succinate	45	16
Azithromycin	Azithromycin	44	35
Meloxicam	Meloxicam	40	15
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Bupropion Xl	Bupropion Hcl	38	12
Escitalopram Oxalate	Escitalopram Oxalate	38	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Ozempic	Semaglutide	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Jardiance	Empagliflozin	29	suppressed
Methocarbamol	Methocarbamol	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	12
Fluticasone Propionate	Fluticasone Propionate	27	16
Ibuprofen	Ibuprofen	27	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Carisoprodol	Carisoprodol	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Atenolol	Atenolol	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	suppressed
Diazepam	Diazepam	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	12
Estradiol	Estradiol	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	15
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	16
Warfarin Sodium	Warfarin Sodium	18	suppressed
Metronidazole	Metronidazole	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Valsartan	Valsartan	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Cevimeline Hcl	Cevimeline Hcl	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Baclofen	Baclofen	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Etodolac	Etodolac	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Naproxen	Naproxen	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sulindac	Sulindac	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Glipizide	Glipizide	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error